Streamlined Localization Using SCOUT® at Biopsy (STREAMLoc )

Official Title

STREAMLoc- Streamlined Localization Using SCOUT® at Biopsy: An Analysis of Process Improvement, Cost Savings and Enhanced Patient Experience.


This registry is intended to demonstrate the utility of the SCOUT® Surgical Guidance system to improve workflow and efficiency in Canadian centres diagnosing and treating breast cancer. The secondary objective is to further evaluate the safety and performance of the SCOUT® Surgical Guidance system in 500 consented BI-RADS 4C/5 according to the IFU.

Trial Description

Primary Outcome:

  • Number of invasive visits
This Canadian registry is intended to assess the utility of SAVI SCOUT® in the Canadian public healthcare system where there are limited resources and a conservative approach to patient and clinician exposure to harm (i.e., radiation, COVID-19 exposure, patient emotional trauma). By assessing the utility of reflector insertion at the time of biopsy, this study will be able to measure the impact on patient visits to the breast centre for invasive procedures between biopsy and surgery, and quantify this value to the public healthcare system. The efficacy and safety of this system will be further assessed, as well as the acceptance of clinicians and patients.

View this trial on

Interested in this trial?

Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.


Canadian Cancer Society

These resources are provided in partnership with the Canadian Cancer Society